Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P05231 (
interleukin-6
)
23,907
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Hypoxia is thought to be a common precursor of coronary artery disease and malignant tumors, both diseases representing the leading causes of death in industrial nations. So far, investigations of oxygen-regulated erythropoietin (EPO) gene expression in the human hepatoma cell lines Hep3B and HepG2 allowed many important insights into the mechanisms of oxygen-sensing, signalling and regulation of an increasing number of oxygen-responsive genes. To differentiate the various signalling pathways involved in EPO production by these two cell lines, we examined several factors that positively influenced EPO expression. The results demonstrate a keen differential effect of cell density and oxygen concentration on EPO induction in Hep3B compared to HepG2 cells. Using optimized cell culture conditions, EPO production rates as high as 1 U EPO per 10(6) Hep3B cells in 24 h could be achieved. We also found a moderate but reproducible positive effect of
CoCl2
on hypoxia-induced EPO expression in Hep3B but a negative
CoCl2
effect on hypoxic induction in HepG2 cells.
CoCl2
inhibited cell growth in a concentration-dependent manner.
Interleukin-6
was synergistic with hypoxia on EPO induction in Hep3B as well as HepG2 cells, and dexamethasone enhanced this effect in Hep3B but not in HepG2 cells. The moderate
CoCl2
-dependent increase of EPO production observed in hypoxic Hep3B cells might indicate that
CoCl2
and hypoxia do not necessarily act via, identical signalling pathways.
...
PMID:Optimal erythropoietin expression in human hepatoma cell lines requires activation of multiple signalling pathways. 985 4
This paper reviews the local hormone endothelin-2 (ET-2), or vasoactive intestinal contractor (VIC), a member of the vasoconstrictor ET peptide family, where ET-2 is the human orthologous peptide of the murine VIC. While ET-2/VIC gene expression has been observed in some normal tissues, ET-2 recently has been reported to act as a tumor marker and as a hypoxia-induced autocrine survival factor in tumor cells. A recently published study reported that the hypoxic mimetic agent
CoCl2
at 200 microM increased expression of the ET-2/VIC gene, decreased expression of the ET-1 gene, and induced intracellular reactive oxygen species (ROS) increase and neurite outgrowth in neuronal model PC12 cells. The ROS was generated by addition of
CoCl2
to the culture medium, and the
CoCl2
-induced effects were completely inhibited by the antioxidant N-acetyl cysteine. Furthermore,
interleukin-6
(
IL-6
) gene expression was up-regulated upon the differentiation induced by
CoCl2
. These results suggest that expression of ET-2/VIC and ET-1 mediated by
CoCl2
-induced ROS may be associated with neuronal differentiation through the regulation of
IL-6
expression.
CoCl2
acts as a pro-oxidant, as do Fe(II, III) and Cu(II). However, some biological activities have been reported for
CoCl2
that have not been observed for other metal salts such as FeCl3, CuSO4, and NiCl2. The characteristic actions of
CoCl2
may be associated with the differentiation of PC12 cells. Further elucidation of the mechanism of neurite outgrowth and regulation of ET-2/VIC expression by
CoCl2
may lead to the development of treatments for neuronal disorders.
...
PMID:Endothelin-2/vasoactive intestinal contractor: regulation of expression via reactive oxygen species induced by CoCl2, and Biological activities including neurite outgrowth in PC12 cells. 1649 22